CHINA PHARMA HOLDINGS, INC. Common Stock and Additional Paid-In Capital
CHINA PHARMA HOLDINGS, INC. (CPHI) had Common Stock and Additional Paid-In Capital of $90.00 thousand as of 2022-10-03, per its 10-K filed 2023-03-30.
Discontinued › Notes › Equity › Stockholders' Equity Note › Class of Stock Disclosures
us-gaap:CommonStocksIncludingAdditionalPaidInCapital · last filed 2023-03-30
- 2022-10-03: Common Stocks, Including Additional Paid in Capital $90.00K.
| Period end | Common Stocks, Including Additional Paid in Capital |
|---|---|
| 2022-10-03 | $90.00K 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |